Dr Hannah Lawson

I am a Senior Postdoctoral Research Fellow at The Institute of Cancer Research (ICR) in London. My work explores how oxygen sensing, metabolism and hypoxia signalling shape blood cancers like acute myeloid leukaemia (AML). By combining advanced in vivo models, multi-omics and drug discovery, I aim to uncover new, non-toxic ways to eliminate leukaemic stem cells and prevent relapse. My research, published in Nature Cancer and recognised among ICR’s “Top 10 Scientific Achievements,” is now supported by a Blood Cancer UK Project Grant to translate these discoveries into new therapies for patients.